Potassium iodide inhibits neutrophil chemotaxis.
DOI:
https://doi.org/10.2340/0001555570247249Abstract
We studied the effect of potassium iodide on the chemotaxis of neutrophil in 15 healthy subjects with a modified Boyden chamber method. Orally administered potassium iodide (15 mg/kg/day for 3 days) significantly inhibited the neutrophil chemotaxis in peripheral blood. It is postulated that the therapeutic effect of potassium iodide on erythema nodosum, nodular vasculitis, and Sweet's syndrome might be mediated through the inhibition of neutrophil chemotaxis by this agent.Downloads
Download data is not yet available.
Downloads
Published
1990-05-01
How to Cite
Honma, K., Saga, K., Onodera, H., & Takahashi, M. (1990). Potassium iodide inhibits neutrophil chemotaxis. Acta Dermato-Venereologica, 70(3), 247–249. https://doi.org/10.2340/0001555570247249
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
